Psychedelic Drugs Market

Global Psychedelic Drugs Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2021-2026 - (By Product, By Disease Indication, By Route of Administration, By Origin, By Geography, Leading Companies)

Published Date: Aug 2021 | Format: | No. of Pages: 140

Industry: Pharmaceuticals & Biotechnology | Author Name: Amol

Request Customisation / Information

FAQ : Psychedelic Drugs Market

Global psychedelic drugs market is anticipated to reach US$6330 Mn by 2026.

Global psychedelic drugs market is anticipated to register a CAGR of 14.5% CAGR between 2021 and 2026.

North America will lead the global psychedelic drugs market as it reaches US$3,184.0 Mn by 2026 from US$1,608.6 Mn in 2021, surging at a CAGR of 14.6% from 2021 to 2026.

Gamma-hydroxybutyric acid (GHB) is anticipated to contribute 37% to the global psychedelic drugs market by the end of 2021.

Intranasal route of administration is slated to exhibit strong CAGR of 17% CAGR with the commercial arrival of Spravato during the forecast period of 2021-2026.

Psychedelic Drugs Market

Request Customisation / Information

FAQ : Psychedelic Drugs Market

What is the Expected Market Value of the Global Psychedelic Drugs Market by the End of Forecast Period?

What will be the CAGR Registered by the Global Psychedelic Drugs Market during the Forecast Period?

Which Region Holds the Highest Value Share on the Global Psychedelic Drugs Market Share Pie?

Which Drug is Estimated to Dominate Global Psychedelic Drugs Market by the end of 2021?

Which Route of Administration Expected to Register Highest Growth during the Forecast Period?